The Impact of State Dementia Training Requirements for Nursing Homes on Antipsychotic Medication Use

被引:2
|
作者
Shier, Victoria [1 ,5 ]
Bae-Shaaw, Yuna H. [2 ]
Sood, Neeraj [1 ]
Lekovitch, Cara [3 ]
Chew, Felicia [4 ]
Leland, Natalie E. [3 ]
机构
[1] Univ Southern Calif, Sol Price Sch Publ Policy, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA 90007 USA
[2] Univ Calif Los Angeles, USC Mann Sch Pharm & Pharmaceut Sci, Titus Family Dept Clin Pharm, Los Angeles, CA USA
[3] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Dept Occupat Therapy, Pittsburgh, PA USA
[4] Thomas Jefferson Univ, Dept Occupat Therapy, Pittsburgh, PA USA
[5] 635 Downey Way, Los Angeles, CA 90089 USA
关键词
Regulations; staff; antipsychotic medications; LONG-TERM-CARE; PSYCHOLOGICAL SYMPTOMS; RISK; RESIDENTS; BURDEN; HYPERLIPIDEMIA; ASSOCIATION; RISPERIDONE; OLANZAPINE; CLOZAPINE;
D O I
10.1016/j.jamda.2023.10.017
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: Nursing home (NH) staff often report not having adequate dementia-specific knowledge to effectively care for these residents. Between 2011 and 2019, 9 states in the United States implemented dementia training requirements for NH staff. This study evaluated whether the state-mandated dementia training for NH staff was associated with improving resident outcomes. Design: Compared trends in antipsychotic medication before and after implementation of state training requirements to trends in states without requirements. Setting and Participants: NHs. Methods: Data from Care Compare for NHs and LTCFocus were linked to state policy data. We excluded 14 states that had implemented training requirements before the start of the study period in 2011. We estimated difference-in-differences models that compared trends in antipsychotic medication use before and after implementation of training requirements in states that have newly implemented requirements to trends in states without requirements. We also investigated whether the impact of training was larger in states with more stringent training requirements (eg, specifying a minimum number of training hours) and in NHs with a special care unit for dementia and examined similar analyses for restraint use and falls. Results: We found that training requirements were associated with a 0.59-percentage point reduction (95% CI -0.91 to -0.27) in antipsychotics use. Effects were larger in NHs with a special care unit for dementia and in states that had stricter training requirements. We also found that training requirements were associated with a 0.17-percentage point reduction (95% CI -0.26 to -0.07) in restraint use measure and had no impact on falls. Conclusions and Implications: State requirements for NH staff dementia training were associated with a small, but significant, reduction in the use of antipsychotic medication and physical restraints. (c) 2023 AMDA - The Society for Post-Acute and Long-Term Care Medicine.
引用
收藏
页码:209 / 214.e1
页数:7
相关论文
共 50 条
  • [21] An effective approach to decrease antipsychotic and benzodiazepine use in nursing homes: the RedUse project
    Westbury, Juanita
    Jackson, Shane
    Gee, Peter
    Peterson, Gregory
    INTERNATIONAL PSYCHOGERIATRICS, 2010, 22 (01) : 26 - 36
  • [22] Impact of Antipsychotic Review and Nonpharmacological Intervention on Antipsychotic Use, Neuropsychiatric Symptoms, and Mortality in People With Dementia Living in Nursing Homes: A Factorial Cluster-Randomized Controlled Trial by the Well-Being and Health for People With Dementia (WHELD) Program
    Ballard, Clive
    Orrell, Martin
    Sun YongZhong
    Moniz-Cook, Esme
    Stafford, Jane
    Whittaker, Rhiannon
    Woods, Bob
    Corbett, Anne
    Garrod, Lucy
    Khan, Zunera
    Woodward-Carlton, Barbara
    Wenborn, Jennifer
    Fossey, Jane
    AMERICAN JOURNAL OF PSYCHIATRY, 2016, 173 (03) : 252 - 262
  • [23] Policy to Reduce Antipsychotic Use and Hospitalization of Nursing Home Residents With Dementia
    Wang, Sijiu
    Temkin-Greener, Helena
    Conwell, Yeates
    Cai, Shubing
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2020, 21 (11) : 1617 - +
  • [24] The impact of facility characteristics on the use of antipsychotic medications in nursing homes: a cross-sectional study
    Dvora Frankenthal
    Gisele Zandman-Goddard
    Yael Ben-Muvhar
    Bat Sheva Porat-Katz
    Israel Journal of Health Policy Research, 5
  • [25] Improving Medication Use in the Nursing Homes: A European Perspective
    Cestac, Philippe
    Tavassoli, Neda
    Vellas, Bruno
    Rolland, Yves
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2013, 14 (01) : 6 - 9
  • [26] Polypharmacy and inappropriate medication use in Singapore nursing homes
    Mamun, K
    Lien, CTC
    Goh-Tan, CYE
    Ang, WST
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2004, 33 (01) : 49 - 52
  • [27] Nursing homes underreport antipsychotic use but overreport diagnoses qualifying for appropriate use
    Chen, Amanda C.
    Grabowski, David C.
    HEALTH AFFAIRS SCHOLAR, 2023, 1 (02):
  • [28] Use of physical restraints and antipsychotic medications in nursing homes: a cross-national study
    Feng, Zhanlian
    Hirdes, John P.
    Smith, Trevor F.
    Finne-Soveri, Harriet
    Chi, Iris
    Du Pasquier, Jean-Noel
    Gilgen, Ruedi
    Ikegami, Naoki
    Mor, Vincent
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2009, 24 (10) : 1110 - 1118
  • [29] Rethinking potentially inappropriate medication use in nursing homes within the Chinese population
    Lin, Yu-Ning
    Tsai, Hsiu-Hsin
    Huang, Hsiu-Li
    Chang, Yue-Cune
    Shieh, Wann-Yun
    GERIATRIC NURSING, 2020, 41 (06) : 724 - 729
  • [30] Effects of Nursing Home Changes in Antipsychotic Use on Outcomes among Residents with Dementia
    Zullo, Andrew R.
    Riester, Melissa R.
    Varma, Hiren
    Daiello, Lori A.
    Gerlach, Lauren B.
    Coe, Antoinette B.
    Thomas, Kali S.
    Joshi, Richa
    Zhang, Tingting
    Shireman, Theresa I.
    Bynum, Julie P. W.
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2025, 26 (03)